tasimelteon + Ethanol + Placebo ethanol
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 19/100
19
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Pharmacodyamics and Pharmacokinetics of Tasimelteon Alone and in Combination With Ethanol
Conditions
Pharmacodyamics and Pharmacokinetics of Tasimelteon Alone and in Combination With Ethanol
Trial Timeline
Apr 1, 2012 → Jun 1, 2012
NCT ID
NCT01578057About tasimelteon + Ethanol + Placebo ethanol
tasimelteon + Ethanol + Placebo ethanol is a phase 1 stage product being developed by Vanda Pharmaceuticals for Pharmacodyamics and Pharmacokinetics of Tasimelteon Alone and in Combination With Ethanol. The current trial status is completed. This product is registered under clinical trial identifier NCT01578057. Target conditions include Pharmacodyamics and Pharmacokinetics of Tasimelteon Alone and in Combination With Ethanol.
Hype Score Breakdown
Clinical
6
Activity
8
Company
5
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01578057 | Phase 1 | Completed |